447 related articles for article (PubMed ID: 20098683)
21. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
Levitskaya J; Coram M; Levitsky V; Imreh S; Steigerwald-Mullen PM; Klein G; Kurilla MG; Masucci MG
Nature; 1995 Jun; 375(6533):685-8. PubMed ID: 7540727
[TBL] [Abstract][Full Text] [Related]
22. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection.
Zetterberg H; Stenglein M; Jansson A; Ricksten A; Rymo L
J Gen Virol; 1999 Feb; 80 ( Pt 2)():457-466. PubMed ID: 10073708
[TBL] [Abstract][Full Text] [Related]
23. The nature and extent of contributions by defective ribosome products to the HLA peptidome.
Bourdetsky D; Schmelzer CE; Admon A
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1591-9. PubMed ID: 24715725
[TBL] [Abstract][Full Text] [Related]
24. Reduction in RNA levels rather than retardation of translation is responsible for the inhibition of major histocompatibility complex class I antigen presentation by the glutamic acid-rich repeat of herpesvirus saimiri open reading frame 73.
Gao J; Coulson JM; Whitehouse A; Blake N
J Virol; 2009 Jan; 83(1):273-82. PubMed ID: 18945762
[TBL] [Abstract][Full Text] [Related]
25. Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasion.
van Gent M; Gram AM; Boer IGJ; Geerdink RJ; Lindenbergh MFS; Lebbink RJ; Wiertz EJ; Ressing ME
J Gen Virol; 2015 Apr; 96(Pt 4):858-865. PubMed ID: 25502648
[TBL] [Abstract][Full Text] [Related]
26. Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands.
Dolan BP; Bennink JR; Yewdell JW
Cell Mol Life Sci; 2011 May; 68(9):1481-9. PubMed ID: 21416150
[TBL] [Abstract][Full Text] [Related]
27. The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules.
Keating S; Prince S; Jones M; Rowe M
J Virol; 2002 Aug; 76(16):8179-88. PubMed ID: 12134023
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
Brooks L; Yao QY; Rickinson AB; Young LS
J Virol; 1992 May; 66(5):2689-97. PubMed ID: 1313894
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus: exploiting the immune system by interfering with defective ribosomal products.
Apcher S; Fahraeus R; Manoury B
Microbes Infect; 2004 Nov; 6(13):1212-8. PubMed ID: 15488741
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing.
Kwun HJ; da Silva SR; Shah IM; Blake N; Moore PS; Chang Y
J Virol; 2007 Aug; 81(15):8225-35. PubMed ID: 17522213
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.
Blake NW; Moghaddam A; Rao P; Kaur A; Glickman R; Cho YG; Marchini A; Haigh T; Johnson RP; Rickinson AB; Wang F
J Virol; 1999 Sep; 73(9):7381-9. PubMed ID: 10438828
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses.
Verweij MC; Ressing ME; Knetsch W; Quinten E; Halenius A; van Bel N; Hengel H; Drijfhout JW; van Hall T; Wiertz EJ
Mol Immunol; 2011 Mar; 48(6-7):835-45. PubMed ID: 21292324
[TBL] [Abstract][Full Text] [Related]
33. Positional bias of MHC class I restricted T-cell epitopes in viral antigens is likely due to a bias in conservation.
Kim Y; Yewdell JW; Sette A; Peters B
PLoS Comput Biol; 2013; 9(1):e1002884. PubMed ID: 23357871
[TBL] [Abstract][Full Text] [Related]
34. Hsp90alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway.
Kunisawa J; Shastri N
Immunity; 2006 May; 24(5):523-34. PubMed ID: 16713971
[TBL] [Abstract][Full Text] [Related]
35. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
Schlager S; Speck SH; Woisetschläger M
J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms of viral immune evasion proteins to inhibit MHC class I antigen processing and presentation.
Zhou F
Int Rev Immunol; 2009; 28(5):376-93. PubMed ID: 19811316
[TBL] [Abstract][Full Text] [Related]
37. Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition.
Tellam J; Smith C; Rist M; Webb N; Cooper L; Vuocolo T; Connolly G; Tscharke DC; Devoy MP; Khanna R
Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9319-24. PubMed ID: 18591662
[TBL] [Abstract][Full Text] [Related]
38. Herpes simplex virus expressing Epstein-Barr virus nuclear antigen 1.
Hummel M; Arsenakis M; Marchini A; Lee L; Roizman B; Kieff E
Virology; 1986 Jan; 148(2):337-48. PubMed ID: 3002038
[TBL] [Abstract][Full Text] [Related]
39. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies.
Khanna R; Burrows SR; Moss DJ; Silins SL
J Virol; 1996 Aug; 70(8):5357-62. PubMed ID: 8764046
[TBL] [Abstract][Full Text] [Related]
40. Quantifying the contribution of defective ribosomal products to antigen production: a model-based computational analysis.
Bulik S; Peters B; Holzhütter HG
J Immunol; 2005 Dec; 175(12):7957-64. PubMed ID: 16339531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]